• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form DEFA14A filed by Spectral AI Inc.

    4/17/25 4:06:02 PM ET
    $MDAI
    Medical/Dental Instruments
    Health Care
    Get the next $MDAI alert in real time by email
    DEFA14A 1 ea0237728-03.htm DEFINITIVE ADDITIONAL MATERIALS

    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    _________________

    SCHEDULE 14A

    _________________

    Proxy Statement Pursuant to Section 14(a) of the
    Securities Exchange Act of 1934

    Filed by the Registrant

     

    ☒

    Filed by a Party other than the Registrant

     

    ☐

    Check the appropriate box:

    ☐

     

    Preliminary Proxy Statement

    ☐

     

    Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))

    ☐

     

    Definitive Proxy Statement

    ☒

     

    Definitive Additional Materials

    ☐

     

    Soliciting Material under Rule 14a-12

    Spectral AI, Inc.
    (Name of registrant as specified in its charter)

    _____________________________________________________________________
    (Name of person(s) filing proxy statement, if other than the registrant)

    Payment of Filing Fee (Check the appropriate box):

    ☒

     

    No fee required.

    ☐

     

    Fee paid previously with preliminary materials.

    ☐

     

    Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11.

     

    C/O TABULATOR, P.O. BOX 8016, CARY, NC 27512-9903 Your vote matters! Spectral AI, Inc. Annual Meeting of Stockholders Wednesday, May 28, 2025 9:30 AM, Central Daylight Time Attend in person: 2515 McKinney Avenue, Suite 1000, Dallas, TX 75201 Attend virtually: www.proxydocs.com/MDAI You must register to attend the meeting online and/or participate at www.proxydocs.com/MDAI For a convenient way to view proxy materials, VOTE, and obtain directions to attend the meeting go to www.proxydocs.com/MDAI To vote your proxy while visiting this site, you will need the 12 digit control number in the box below. This communication presents only an overview of the more complete proxy materials that are available to you on the Internet. This is not a ballot. You cannot use this notice to vote your shares. We encourage you to access and review all of the important information contained in the proxy materials before voting. Under United States Securities and Exchange Commission rules, proxy materials do not have to be delivered in paper. Proxy materials can be distributed by making them available on the internet. If you want to receive a paper or e-mail copy of the proxy material, you must request one. There is no charge to you for requesting a copy. In order to receive a paper package in time for this year’s meeting, you must make this request on or before May 16, 2025. SEE REVERSE FOR FULL AGENDA Meeting Materials: Notice of Meeting and Proxy Statement & Annual Report on Form 10-K Important Notice Regarding the Availability of Proxy Materials for the Stockholders Meeting To Be Held On May 28, 2025 For Stockholders of record as of March 31, 2025 To order paper materials, use one of the following methods. Internet: www.investorelections.com/MDAI Call: 1-866-648-8133 Email: [email protected] * If requesting material by e-mail, please send a blank e-mail with the 12 digit control number (located below) in the subject line. No other requests, instructions OR other inquiries should be included with your e-mail requesting material. Your control number Have the 12 digit control number located in the box above available when you access the website and follow the instructions. Copyright © 2025 BetaNXT, Inc. or its affiliates. All Rights Reservedv

     

    Spectral AI, Inc. Annual Meeting of Stockholders THE BOARD OF DIRECTORS RECOMMENDS A VOTE: FOR ON PROPOSALS 1 AND 2 PROPOSALS 1. To elect six directors, each until the next Annual Meeting of Stockholders and until each of their respective successors has been duly elected and qualified; 1.01 Dr. J. Michael DiMaio 1.02 Colin Bristow 1.03 Richard Cotton 1.04 Martin Mellish 1.05 Deepak Sadagopan 1.06 Marion Snyder 2. To ratify the appointment of KPMG LLP as the Company’s independent registered public accounting firm for the 2025 fiscal year. 3. To transact any other business as may properly come before the meeting.

     

    Get the next $MDAI alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $MDAI

    DatePrice TargetRatingAnalyst
    1/23/2024$4.00Buy
    BTIG Research
    More analyst ratings

    $MDAI
    SEC Filings

    See more
    • SEC Form EFFECT filed by Spectral AI Inc.

      EFFECT - Spectral AI, Inc. (0001833498) (Filer)

      5/8/25 12:15:21 AM ET
      $MDAI
      Medical/Dental Instruments
      Health Care
    • Amendment: SEC Form S-3/A filed by Spectral AI Inc.

      S-3/A - Spectral AI, Inc. (0001833498) (Filer)

      5/2/25 4:04:29 PM ET
      $MDAI
      Medical/Dental Instruments
      Health Care
    • SEC Form S-3 filed by Spectral AI Inc.

      S-3 - Spectral AI, Inc. (0001833498) (Filer)

      4/24/25 9:00:39 PM ET
      $MDAI
      Medical/Dental Instruments
      Health Care

    $MDAI
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Dimaio John Michael bought $10,320 worth of shares (6,000 units at $1.72), increasing direct ownership by 0.40% to 2,491,908 units (SEC Form 4)

      4 - Spectral AI, Inc. (0001833498) (Issuer)

      5/14/24 11:17:43 AM ET
      $MDAI
      Medical/Dental Instruments
      Health Care

    $MDAI
    Financials

    Live finance-specific insights

    See more
    • Spectral AI Schedules 2025 First Quarter Financial Results and Conference Call

      DALLAS, May 02, 2025 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (NASDAQ:MDAI) ("Spectral AI" or the "Company"), a leading developer of the AI-driven DeepView® System, which uses multi-spectral imaging and AI algorithms to predict burn healing potential today announced that it will report financial results for the first quarter ended March 31, 2025 on Tuesday, May 13, 2025 after the close of the stock market. The Company will host a corresponding conference call at 5:00 pm Eastern Time to discuss the results. Investors interested in participating in the live call can dial: 833-630-1956 - U.S.412-317-1837 - International A simultaneous webcast of the call may be accessed online from the Events

      5/2/25 4:00:00 PM ET
      $MDAI
      Medical/Dental Instruments
      Health Care
    • Spectral AI Announces 2024 Fourth Quarter and Full Year Financial Results

      2024 Research & Development Revenue of $30 Million Successful Results from the US Burn Validation Study On Track for Regulatory Submission in US for DeepView™ System DALLAS, March 27, 2025 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (NASDAQ:MDAI) ("Spectral AI" or the "Company"), an artificial intelligence ("AI") company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, today announced financial results for the fourth quarter ("Q4 2024") and full year ("FY 2024") ended December 31, 2024, and provided an update on its ongoing business activities. "Spectral AI achieved much in 2024. Our top-l

      3/27/25 4:55:44 PM ET
      $MDAI
      Medical/Dental Instruments
      Health Care
    • Spectral AI Schedules 2024 Fourth Quarter and Full Year Financial Results and Conference Call

      DALLAS, Feb. 28, 2025 (GLOBE NEWSWIRE) -- Spectral AI (NASDAQ:MDAI) ("Spectral AI" or the "Company"), developer of the AI-driven DeepView® System, which received Breakthrough Device Designation from the U.S. Food and Drug Administration ("FDA") in 2018 and uses multi-spectral imaging and AI algorithms to predict burn healing potential, today announced that it will report financial results for the fourth quarter and full year ended December 31, 2024 on Wednesday, March 27, 2025 after the close of the stock market. The Company will host a corresponding conference call at 5:00 pm Eastern Time to discuss the results. Investors interested in participating in the live call can dial: 844-481-30

      2/28/25 8:00:00 AM ET
      $MDAI
      Medical/Dental Instruments
      Health Care

    $MDAI
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more

    $MDAI
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • BTIG Research initiated coverage on Spectral AI with a new price target

      BTIG Research initiated coverage of Spectral AI with a rating of Buy and set a new price target of $4.00

      1/23/24 7:24:00 AM ET
      $MDAI
      Medical/Dental Instruments
      Health Care
    • Spectral AI Schedules 2025 First Quarter Financial Results and Conference Call

      DALLAS, May 02, 2025 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (NASDAQ:MDAI) ("Spectral AI" or the "Company"), a leading developer of the AI-driven DeepView® System, which uses multi-spectral imaging and AI algorithms to predict burn healing potential today announced that it will report financial results for the first quarter ended March 31, 2025 on Tuesday, May 13, 2025 after the close of the stock market. The Company will host a corresponding conference call at 5:00 pm Eastern Time to discuss the results. Investors interested in participating in the live call can dial: 833-630-1956 - U.S.412-317-1837 - International A simultaneous webcast of the call may be accessed online from the Events

      5/2/25 4:00:00 PM ET
      $MDAI
      Medical/Dental Instruments
      Health Care
    • Burn clinicians present positive findings of the DeepView® System's accuracy at the American Burn Association annual meeting

      DALLAS, April 30, 2025 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (NASDAQ:MDAI) ("Spectral AI" or the "Company"), a leading developer of the AI-driven DeepView® System, which uses multi-spectral imaging and AI algorithms to predict burn healing potential today announced its successful participation at the American Burn Association annual meeting, dedicated to burn awareness and prevention. The event, held from April 7th - 11th in Phoenix, Arizona, brought together over 2,200 burn care professionals worldwide. This year's meeting showcased the latest advancements in burn care, fostered interdisciplinary collaboration, and celebrated the burn care community's dedication. Burn and Plastics Senior

      4/30/25 4:00:00 PM ET
      $MDAI
      Medical/Dental Instruments
      Health Care
    • FDA Watch: The Quiet Gold Rush in AI-Powered Medical Devices

      Equity Insider News Commentary Issued on behalf of Avant Technologies Inc. VANCOUVER, BC, April 2, 2025 /PRNewswire/ -- Equity Insider News Commentary – Artificial Intelligence (AI) is quickly becoming a major force in healthcare, as use of AI applications in medical fields is growing rapidly. Researchers at Dartmouth recently conducted the first clinical trial of a therapy chatbot powered by generative AI (genAI), and found that it resulted in significant improvements in participants' symptoms. Cleveland Clinic and UAE-based G42 recently started collaborating on the advancement of even more AI in healthcare adoption, signalling an international push in this revolution. Because of this, the

      4/2/25 11:04:00 AM ET
      $AAPL
      $AMZN
      $GEHC
      $MDAI
      Computer Manufacturing
      Technology
      Catalog/Specialty Distribution
      Consumer Discretionary

    $MDAI
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Cotton Richard John was granted 9,699 shares, increasing direct ownership by 17% to 66,927 units (SEC Form 4)

      4 - Spectral AI, Inc. (0001833498) (Issuer)

      5/1/25 4:00:30 PM ET
      $MDAI
      Medical/Dental Instruments
      Health Care
    • Director Mellish Martin C.B. was granted 9,699 shares, increasing direct ownership by 100% to 19,398 units (SEC Form 4)

      4 - Spectral AI, Inc. (0001833498) (Issuer)

      4/30/25 5:02:54 PM ET
      $MDAI
      Medical/Dental Instruments
      Health Care
    • CFO and General Counsel Capone Vincent S. was granted 100,000 shares, increasing direct ownership by 508% to 119,700 units (SEC Form 4)

      4 - Spectral AI, Inc. (0001833498) (Issuer)

      4/30/25 5:02:34 PM ET
      $MDAI
      Medical/Dental Instruments
      Health Care

    $MDAI
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13G/A filed by Spectral AI Inc.

      SC 13G/A - Spectral AI, Inc. (0001833498) (Subject)

      11/14/24 4:09:49 PM ET
      $MDAI
      Medical/Dental Instruments
      Health Care
    • SEC Form SC 13G/A filed by Spectral AI Inc. (Amendment)

      SC 13G/A - Spectral AI, Inc. (0001833498) (Subject)

      4/19/24 6:49:51 PM ET
      $MDAI
      Medical/Dental Instruments
      Health Care
    • SEC Form SC 13D/A filed by Spectral AI Inc. (Amendment)

      SC 13D/A - Spectral AI, Inc. (0001833498) (Subject)

      2/27/24 2:07:28 PM ET
      $MDAI
      Medical/Dental Instruments
      Health Care

    $MDAI
    Leadership Updates

    Live Leadership Updates

    See more
    • Spectral AI Set to Join Russell Microcap® Index

      DALLAS, May 29, 2024 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (NASDAQ:MDAI) ("Spectral AI" or the "Company"), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, today announced that it is set to join the Russell Microcap® Index at the conclusion of the 2024 Russell US Indexes annual reconstitution, effective following the closing of US equity markets on Friday, June 28, 2024 according to a preliminary list of additions posted Friday, May 24, 2024. The annual Russell US Indexes reconstitution captures the 4,000 largest US stocks as of Tuesday, April 30, 2024 ranking them by total market capitalization. Members

      5/29/24 8:31:22 AM ET
      $MDAI
      Medical/Dental Instruments
      Health Care
    • Spectral AI Announces Voting Results from 2024 Annual Meeting of Stockholders and the Appointment of Erich Spangenberg to the Board of Directors

      DALLAS, May 15, 2024 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (NASDAQ:MDAI) ("Spectral AI" or the "Company"), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, today announced results from its 2024 Annual Meeting of Stockholders held on May 14, 2024 (the "AGM"). At the AGM, stockholders overwhelmingly approved each of the four proposals set forth by the Company. The voting results are detailed below. Six directors were elected to serve until the next Annual Meeting of Stockholders: Richard Cotton, Chairman of the Company's Board of DirectorsPeter M. Carlson, Chief Executive Officer of the

      5/15/24 6:05:21 PM ET
      $MDAI
      Medical/Dental Instruments
      Health Care
    • Spectral AI Appoints Jeremiah Sparks as Chief Commercialization Officer

      DALLAS, April 01, 2024 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (NASDAQ:MDAI) ("Spectral AI" or the "Company"), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, today announced the appointment of Jeremiah A. Sparks as Chief Commercialization Officer. Jeremiah has more than 20 years of medical device marketing experience, including global marketing and business strategy. Mr. Sparks will be responsible for both domestic and international product commercialization. "We are thrilled to have Jeremiah join the company as we move towards commercialization of DeepView," said Peter M. Carlson, CEO of Spectral AI.

      4/1/24 9:00:00 AM ET
      $MDAI
      Medical/Dental Instruments
      Health Care